SAN MARINO, Calif. and BOSTON, Mass. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on "The Advent of Pathotropic Medicine for Cancer" at the Global Pharma R&D Summit 2007 to be held in Boston MA. On October 22, 2007 at 8:00 a.m., Dr. Hall will present the scientific principles, the clinical validation, and global development status.

FRESNO, Calif. -- Cypress Systems, Inc, a Fresno CA based biotechnology company, emphasizes that the SELECT TRIAL results - that were announced yesterday -...

NEW YORK, N.Y. -- Eularis is announcing the release of an update to its report "Pharmaceutical eMarketing: Building Brands, Relationships & Business Through Web...

NEWS: Council for Vaccine Safety, and A Voice for Choice, in collaboration with community leaders, announce that on October 24, 2015 at 12 noon, protesters will rally at Frank Ogawa Plaza in Oakland, Calif. in solidarity with the Truth, Transparency and Freedom Rally happening on the same day at the CDC in Atlanta, Georgia.

ORLANDO, Fla. -- Natalie Waples is one of the brightest young stars in the fitness firmament. The eye-catching Canadian made her pro debut last...

NEWS: According to Harbor Compounding Pharmacy, many insurance plans are dropping coverage of compounded medications -- but some insurance plans still do cover for these custom formulations. Harbor Compounding Pharmacy provides resources and referrals to patients to find insurance coverage for their compounded medications during open enrollment 2016.

CHICAGO, Ill. /eNewsChannels/ -- NEWS: Nutronics Labs, a Natural supplement company, today released a statement encouraging deer antler spray consumers to do thorough product research before buying health supplements online. Nutronics Labs is the leading manufacturer of deer antler spray and boasts the world's strongest supplements available.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration...

ATLANTA, Ga. /eNewsChannels/ -- CMI, a full-service marketing research company, has been chosen for the second consecutive year to present a session at The Fourth Annual Meeting of the PMRG Institute in Boston, Mass., on Oct. 24-26, 2010. The theme for this year's conference is 'Navigating Healthcare's Shifting Currents: Essential Techniques for the Healthcare Marketing Researcher.'

FORT LAUDERDALE, Fla. -- The Silver Safety Committee this week announced its creation of the Silver Safety Pyramid, which is designed to enable anyone...